[Frontiers in Bioscience 3, d532-547, June 8, 1998]

Table of Conents
 Previous Section   Next Section


Amy S. Yee, Heather H. Shih, and Sergei G. Tevosian

The Department of Biochemistry, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111

Received 5/10/98 Accepted 5/29/98


1. Yan, Z., DeGregori, J., Shohet, R., Leone, G., Stillman, B., Nevins, J. R. and Williams, R. S.: Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl. Acad. Sci. USA. 95,3603-3608 (1998).

2. Krek, W., Xu, G. and Livingston, D. M.: Cyclin A-kinase regulation of E2F-1 binding function underlies suppression of an S-phase checkpoint. Cell. 83,1149-58 (1995).

3. Dynlacht, B., Flores, O., Lees, J. A. and Harlow, E.: Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes and Dev. 8,1772-1786 (1994).

4. Xu, M., Sheppard, K. A., Peng, C. Y., Yee, A. S. and Piwnica-Worms, H.: Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14,8420-8431 (1994).

5. Farnham, P. J. 1996. Transcriptional control of cell growth: the E2F family, vol. 208. Springer Verlag, New York.

6. Nevins, J. R., Leone, G., DeGregori, J. and Jakoi, L.: Role of the Rb/E2F pathway in cell growth control. J Cell Physiol. 173,233-236 (1997).

7. Mayol, X. and Grana, X.: The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions. Front.Biosci.3, d11-24 (1998). http://www.bioscience. org/1998\v3\d\mayol\list.htm

8. Johnson, D. G. and Schneider-Broussard, R.: The role of E2F in the cell cycle and cancer. Front Biosci 3, d447-448 (1998).http://www.bioScience.org/1998\v3\d\johnson1\list.htm

9. Campanero, M. and Flemington, E. K.: Regulation of E2F through ubiquitin-proteosome dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA. 94,2221-6 (1997).

10. Hateboer, G., Kerkhoven, R. M., Shvarts, A., Bernards, R. and Beijersbergen, R. L.: Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes and Dev. 10,2960-2970 (1996).

11. Hoffmann, F., Martelli, F., Livingston, D. M. and Wang, Z.: The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes and Dev. 10,2949-59 (1996).

12. Helin, K., Holm, K., Niebuhr, A., Eiberg, H., Tommerup, N., Hougaard, S., Poulsen, H. S., Spang-Thomsen, M. and Norgaard, P.: Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc. Natl. Acad. Sci. USA. 94,6933-6938 (1997).

13. Shan, B., Durfee, T. and Lee, W. H.: Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA. 93,679-684 (1996).

14. Wang, J. Y. J., Knudsen, E. S. and Welch, P. J.: The retinoblastoma tumor suppressor gene. Adv. in Cancer Res. 64,25-85 (1994).

15. Woo, M. S., Sanchez, I. and Dynlacht, B. D.: p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 17,3566-3579 (1997).

16. Adams, P. D., Sellers, W. R., Sharma, S. K., Wu, A. D., Nalin, C. M. and Kaelin, W. G. J.: Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16, 6623-6633 (1996).

17. Paggi, M. G., Baldi, A., Bonetto, F. and Giordano, A.: Retinoblastoma protein family in cell cycle and cancer: a review. Cell Biochem. 62,418-430 (1996).

18. Lin, S. C., Skapek, S. X. and Lee, E. Y.: Genes in the RB pathway and their knockout in mice. Seminars Cancer Biol. 7,279-289 (1996).

19. Jacks, T., Fazeli, E. M., Schmitt, E., Bronson, R. T., Goodell, M. A. and Weinberg, R. A.: Effects of an Rb mutation in mice. Nature (London). 359,295-300 (1992).

20. Lee, E. Y.-H. P., Hu, N., Yuan, S.-S. F., Cox, L., Bradley, A., Lee, W.-H. and Herrup, K.: Dual roles of the retinoblastoma proteins in cell cycle regulation and neuron differentiation. Genes and Dev. 8,2008-2021 (1994).

21. Lee, E. H. Y. P., Chang, C. Y., Hu, N., Wang, Y. C. J., Lai, C. C., Herrup, K., Lee, W. H. and Bradley, A.: Mice deficient for Rb are nonviable and show defects in neuogenesis and hematopoiesis. Nature (London). 359,288-294 (1992).

22. Riley, D. J., Lee, E. Y.-H. P. and Lee, W.-H.: The retinoblastoma protein: more than a tumor suppressor. Ann Rev Cell Biol10,1-29 (1994).

23. Zackenhaus, E., Jiang, Z., Chung, D., Marth, J. D., Phillips, R. A. and Gallie, B. L.: pRB controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes and Dev. 10,3051-3064 (1996).

24. Cobrinik, D., Lee, M. H., Hannon, G., Mulligan, G., Bronson, R. T., Dyson, N., Harlow, E., Beach, D., Weinberg, R. A. and Jacks, T.: Shared role of the pRB-related p130 and p107 protein in limb development. Genes and Dev. 10,1633-1644 (1996).

25. Lee, M. H., Williams, B. O., Mulligan, G., Mukai, S., Bronson, R. T., Dyson, N., Harlow, E. and Jacks, T.: Targeted disruption of p107:functional overlap betwennp107 and Rb. Genes and Dev. 10,1621-1632 (1996).

26. Hurford, R. K., Cobrinik, D., Lee, M.-H. and Dyson, N.: pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes and Dev. 11,1447-1463 (1997).

27. Mulligan, G. J., Wong, J. and Jacks, T.: p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol. Cell. Biol. 18,206-220 (1998).

28. Tevosian, S. G., Shih, H., Mendelson, K. G., Sheppard, K. A., Paulson, K. E. and Yee, A. S.: HBP-1: A new transcriptional repressor that is targetted of the retinoblastoma family. Genes and Dev. 11,383 - 396 (1997).

29. Maione, R., Fimia, G., Holman, P., Schaffhausen, B. and Amati, P.: Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell, Growth & Diff. 5,231-237 (1994).

30. Corbeil, H., Whyte, P. and Branton, P. E.: Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene. 11,909-920 (1995).

31. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V. and Nadal-Ginard, B.: Reversal of terminal differentiation mediated by p107 in Rb -/- muscle cells. Science. 264,1467-1470 (1994).

32. Maione, R. and Amati, P.: Interdependence between muscle differentiation and cell cycle control. Biochim Biophys. Acta. 1332,M19-M30 (1997).

33. Mayol, X., Garriga, J. and Grana, X.: G1 cyclin/CDK independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association wirh p130. Oncogene. 13,237-246 (1996).

34. Smith, E. J., Leone, G., DeGregori, J., Jakoi, L. and J.R., N.: The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state Mol. Cell. Biol. 16,6965-6976 (1996).

35. Shin, E., Shin, A., Paulding, C., Schaffhausen, B. and Yee, A. S.: Multiple changes in E2F transcription Factor function occur upon muscle differentiation. Mol. Cell. Biol. 15,2252-2262 (1995).

36. Cobrinik, D., Whyte, P., Peeper, D., Jacks, T. and Weinberg, R.: Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes and Dev. 7,2392-2404 (1993).

37. Altiok, S., Xu, M. and Spiegelman, B. M.: PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes and Dev. 11,1987-1998 (1997).

38. Sellers, W. R. and Kaelin, W. G. J.: RB [corrected] as a modulator of transcription. Biochim Biophys Acta. 1288 (1),M1-M5 (1996).

39. Kaelin, W. G., Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchanbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., Livingston, D. M. and Flemington, E. K.: Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 70,351-364 (1992).

40. Sellers, W., R. , Rodgers, J., W. and Kaelin, W. G. J.: A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92,11544-8 (1995).

41. Chow, K. N. and Dean, D. C.: Domains A and B in the RB pocket interact to form a transcriptional repressor motif. Mol. Cell. Biol. 16,4862-4868 (1996).

42. Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J. and Kouzarides, T.: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (London). 391,597-600 (1998).

43. Luo, R., Postigio, A. and Dean, D. C.: RB interacts with histone deacetylase to repress transcription. Cell. 92,462-473 (1998).

44. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Villain, J. P., Troalen, F., Trouche, D. and Harel-Bellan, A.: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature (London). 391,601-4 (1998).

45. Struhl, K.: Histone acetylation and transcriptional regulatory mechanisms. Genes and Dev. 12,599-606 (1998).

46. Yee, A. S., Raychaudhuri, P., Jakoi, L. and Nevins, J. R.: The adenovirus-inducible factor E2F stimulates transcription following specific DNA binding. Mol. Cell. Biol. 9,578-585 (1989).

47. Singh, P., Coe, J. and Hong, W.: A role for the retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature (London). 374,562-565 (1995).

48. Defeo-Jones, D., Huang, P., Jones, R., Haskell, K., Vuocolo, G., Hanobik, M., Huber, H. and Oliff, A.: Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature (London). 352,251-253 (1991).

49. Dowdy, S. F., Hinds, P. W., Louie, P., Reed, S. I. and Weinberg, R. A.: Physical interaction of the retinoblastoma protein with D-type cyclins. Cell. 73,499-511 (1993).

50. Ewen, M., Sluss, H. K., Sherr, C. J., Matsuhime, H., Kato, J. and Livingston, D. M.: Functional interactions of retinoblastoma and D-type cyclins. Cell. 73,487-97 (1993).

51. Buyse, I., Shao, G. and Huang, S.: The retinoblastoma protein binds to RIZ, a zincfinger protein that shares an epitope with the adenovirus E1A protein. Proc. Natl. Acad. Sci. USA. 92,4467-4471 (1995).

52. Dunaief, J. L., Strober, B. E., Guha, S., Khavari, P. A., Alin, K., Luban, J., Begemann, M., Crabtree, G. and Goff, S.: The retinoblastoma protein and BRG1 form a a complex and cooperate to induce cell cycle arrest. Cell. 79,119-130 (1994).

53. Wang, C. Y., Petryniak, B., Thompson, C. B., Kaelin, W. G. and Leiden, J. M.: Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science,1330-1335 (1993).

54. Lavender, P., Vandel, L., Bannister, A. J. and Kouzarides, T.: The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene. 14,2721-2728 (1997).

55. Lesage, F., Hugnot, J. P., Amri, E. Z., Grimaldi, P., Barhanin, J. and Lazdunski, M.: Expression cloning in the K+transport-defective yeast and regulation of HBP1, a new putative HMG transcriptional regulator. Nucl. Acids. Res. 22,3685-3688 (1994).

56. Love, J. J., Li, X., Case, D. A., Giese, K., Grosschedl, R. and Wright, P. E.: Structural basis for DNA bending by the architectural transcription factor Lef -1. Nature (London). 376,791-795 (1995).

57. Grosschedl, R.: Higher order nucleoprotein complexes in transcription: analogies with site-specific recombination. Current Opin Cell Biol. 7,362-70 (1995).

58. Hunter, T.: Oncoprotein Networks. Cell. 88,333-346 (1997).

59. Mudryj, M., Hiebert, S. and Nevins, J. R.: A role for the adenovirus-inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9,2179-2184 (1990).

60. Sherr, C. J.: Cancer cell cycles. Science. 274,1672-1677 (1996).

61. Novitch, B. G., G.J., M., Jacks, T. and Lassar, A. B.: Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell. Biol. 135,441-56 (1996).

62. Wang, J. Y. J.: Retinoblastoma protein in growth suppression and death. Curr. Opin. Gen. & Dev. 7,39-45 (1997).

63. Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y. H. P., Bradley, A., Li, W., Bertino, J. and Wahl, G. M.: Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes and apoptosis. Proc. Natl. Acad. Sci. USA. 92,5436-5440 (1995).

64. Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. and Israel, M.: Inhibition of apoptosis by the retinoblastoma gene. EMBO J. 14,461-472 (1995).

65. Tan, X., Martin, S. J., Green, D. R. and Wang, J. Y. J.: Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 272, 9613-9616 (1997).

66. Janicke, R. U., Walker, P. A., Lin, X. Y. and Porter, A. G.: Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15,6969-6978 (1996).

67. Dou, Q.-P. and An, B.: RB and apoptotic cell death. Front.Biosci.. 3,d419-430 (1998). http://www.bioscience. org/1998\v3\d\dou\list.htm

68. Walsh, K. and Perlman, H.: Cell cycle exit upon myogenic differentiation. Curr. Opin. Gen. & Dev. 7,597-602 (1997).

69. Morgenbesser, S. D., Williams, B. O., Jacks, T. L. and Depinho, R. A.: p53-dependendent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (London). 371,72-74 (1996).

70. Macleod, K. F., Hu, Y. and Jacks, T.: Loss of RB activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. (1996).

71. Wang, J. and Walsh, K.: Resistance to apoptosis conferred by cdk inhibitors in myocyte differentiation. Science. 273,359-361 (1996).

72. Guo, K., Wang, J., Andres, V., Smith, R. C. and Walsh, K.: MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15,3823-9 (1995).

73. Halavey, O., Novitch, B., Spicer, D. B., Skapek, S., Rhee, J., Hannon, G. J., Beach, D. and Lassar, A. B.: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267,1018-1021 (1995).

74. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W. and Elledge, S. J.: p53-independent expression of p21 cip1 in muscle and other terminally differentiated cells. Science. 267,1024-1026 (1995).

75. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. and Jacks, T.: p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes and Dev. 9,935-944 (1995).

76. Wang, J., Guo, K., Wills, K. N. and Walsh, K.: RB functions to inhibit apoptosi during myocyte differentiation. Cancer Res.57,351-54 (1997).

77. Molkentin, J. D. and Olson, E. N.: Defining the regulatory networks for muscle development.Curr opin Genetics Dev 6,445-53 (1996).

78. Molkentinin, J. and Olson, E. N.: Combinatorial control of muscle development by helix-loop-helix and MADS box transcription factors. Proc. Natl. Acad. Sci. USA. 93,9366-9373 (1996).

79. Condorelli, G. and Giordano, A.: Synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation. J Cell Biochem. 67,423-431 (1997).

80. Olson, E. N. and Klein, W. H.: bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes and Dev. 8,1-8 (1994).

81. Brun, R. P., J.B., K., Hu, E., Altiok, S. and Spiegelman, B. M.: Adipocyte differentiation: a transcriptional regulatory cascade. Current Opin Cell Biol. 6,826 (1996).

82. Peterson, C., Gordon, H., Hall, Z., Paterson, B. and Blau, H.: Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell. 62,493-502 (1990).

83. Puri, P. L., Balsano, C., Burgio, V. L., Chirillo, P., Natoli, G., Ricci, L., Mattei, E., Graessmann, A. and Levrero, M.: MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes. Oncogene. 14,1171-1184 (1997).

84. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V. and Nadal-Ginard, B.: Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72,309-324 (1993).

85. Yeh, W. C., Cao, Z., Classon, M. and McKnight, S. L.: Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes and Dev. 9,168-81 (1995).

86. Chen, P. L., Riley, D. J., Chen, Y. and Lee, W. H.: Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes and Dev. 10,2794 -2804 (1996).

87. Sellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B. and Kaelin, W. G. J.: Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes and Dev. 12,95-106 (1998).

88. Riley, D. J., Liu, C. Y. and Lee, W. H.: Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression. Mol. Cell. Biol. 17,7342-7352 (1997).

89. Batchvarova, N., Wang, X. Z. and Ron, D.: Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 14,4654-61 (1995).

90. Shih, H., Tevosian, S. G. and Yee, A. S.: Regulation of Differentiation by HBP1, a Target of the Retinoblastoma Protein. Mol. Cell. Biol. In press 18, (1998).

91. Datta, B., Min, W., Burma, S. and Lengyel, P.: Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity of p202. Mol. Cell. Biol. 18,1074-1083 (1998).

92. Classon, M., Gorka, C., Kennedy, B. K., Dyson, N. and Harlow, E.: Opposing roles for pRB and p107/p130 in adipocyte differentiation. Genes and Dev. submitted,(1998).

93. Choubey, D. and Lengyel, P.: Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J. Biol. Chem. 270,6134-6140 (1995).

94. Choubey, D., Li, S.-J., Datta, B., Gutterman, J. U. and Lengyel, P.: Inhibition of E2F-mediated transcription by p202. EMBO J. 15,5668-5678 (1996).

95. Ron, D. and Habener, J. F.: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes and Dev. 6,439-53 (1992).

96. Crozat, A., Aman, P., Mandahl, N. and Ron, D.: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (London). 363,640-4 (1993).

97. Barone, M. V., Crozat, A., Tabaee, A., Philipson, L. and Ron, D.: CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8,453-64 (1994).

98. Di Cunto, F., Topley, G., Calautti, E., Hsiao, J., Ong, L., Seth, P. K. and Dotto, G. P.: Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science. 280,1069-1072 (1998).

99. Sugiyama, A., Miyagi, Y., Shirasawa, Y. and Kuchino, T.: Different usage of two polyadenylation signals in transcription of the N-Myc gene in rat tumor cells. Oncogene. 11,2027-2032 (1991).

100. Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I. W., Karnezis, A. N., L., Z., Kyriakis, J., Rundell, K. and Pestell, R. G.: Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA. 23,12861 (1995).